IT603
/ ImmuneTarget
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 14, 2022
c-Rel dependant Chk2 signalling regulates the DNA damage response limiting hepatocarcinogenesis.
(PubMed, Hepatology)
- "Hepatocyte c-Rel signalling limits genotoxic injury, and subsequent HCC burden. Inhibiting c-Rel as an adjuvant therapy increased the effectiveness of DNA damaging agents and reduced HCC growth."
Journal • Gastrointestinal Cancer • Hepatocellular Cancer • Oncology • Solid Tumor • CHEK2 • TMB
September 29, 2019
A COMMON METABOLIC SWITCH CONTROLS HEPATOCYTE AND MACROPHAGE PHENOTYPE MODULATION IN LIVER INJURY AND IS REQUIRED FOR FIBROSIS.
(AASLD 2019)
- "Metabolic reprogramming of epithelial cells and macrophages is a critical event during fibrogenesis that is control by a common transcription factor, c-Rel. As such development of c-Rel inhibitors represents an exciting new approach to treat chronic liver disease and fibrosis."
1 to 2
Of
2
Go to page
1